PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.54%
Positive revenue growth while 2127.T is negative. John Neff might see a notable competitive edge here.
2.13%
Positive gross profit growth while 2127.T is negative. John Neff would see a clear operational edge over the competitor.
-4.04%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
8.13%
Positive operating income growth while 2127.T is negative. John Neff might view this as a competitive edge in operations.
-4.25%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-4.26%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-4.26%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.00%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.00%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
38.82%
10Y revenue/share CAGR under 50% of 2127.T's 613.65%. Michael Burry would suspect a lasting competitive disadvantage.
-10.63%
Negative 5Y CAGR while 2127.T stands at 233.10%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
34.92%
3Y revenue/share CAGR similar to 2127.T's 37.01%. Walter Schloss would assume both companies experience comparable short-term cycles.
100.00%
10Y OCF/share CAGR in line with 2127.T's 100.00%. Walter Schloss would see both as similarly efficient over the decade.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
189.89%
Below 50% of 2127.T's 1769.68%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
14.72%
Below 50% of 2127.T's 343.16%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
61.26%
3Y net income/share CAGR above 1.5x 2127.T's 18.25%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
132.27%
10Y equity/share CAGR at 50-75% of 2127.T's 252.62%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
27.36%
Below 50% of 2127.T's 135.68%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
68.35%
3Y equity/share CAGR 1.25-1.5x 2127.T's 52.40%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-2.78%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-2.34%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-0.61%
Negative asset growth while 2127.T invests at 0.07%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
3.83%
Positive BV/share change while 2127.T is negative. John Neff sees a clear edge over a competitor losing equity.
-6.07%
We’re deleveraging while 2127.T stands at 4900.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
0.53%
We expand SG&A while 2127.T cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.